Mice with control NCI-H460-LNM35 tumours (i.e. not expressing soluble VEGFR-3) were treated with recombinant adenovirus expressing soluble VEGFR-3 as an alternative inhibitory strategy – this also restricted lymph node metastasis (He et al, 2002). The gene discussed is FLT4; the disease is neoplasm.